What is the share price of Ganga Pharmaceuticals Ltd (GANGAPHARM) today?
The share price of GANGAPHARM as on 23rd May 2025 is ₹13.32. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Ganga Pharmaceuticals Ltd (GANGAPHARM) share?
The past returns of Ganga Pharmaceuticals Ltd (GANGAPHARM) share are- Past 1 week: N/A%
- Past 1 month: N/A%
- Past 3 months: 30.97%
- Past 6 months: -26%
- Past 1 year: -46.01%
- Past 3 years: 29.70%
- Past 5 years: 66.50%
What are the peers or stocks similar to Ganga Pharmaceuticals Ltd (GANGAPHARM)?
The peers or stocks similar to Ganga Pharmaceuticals Ltd (GANGAPHARM) include:What is the market cap of Ganga Pharmaceuticals Ltd (GANGAPHARM) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Ganga Pharmaceuticals Ltd (GANGAPHARM) is ₹6.44 Cr as of 23rd May 2025.What is the 52 week high and low of Ganga Pharmaceuticals Ltd (GANGAPHARM) share?
The 52-week high of Ganga Pharmaceuticals Ltd (GANGAPHARM) is ₹27.10 and the 52-week low is ₹9.25.What is the PE and PB ratio of Ganga Pharmaceuticals Ltd (GANGAPHARM) stock?
The P/E (price-to-earnings) ratio of Ganga Pharmaceuticals Ltd (GANGAPHARM) is 80.53. The P/B (price-to-book) ratio is 0.91.Which sector does Ganga Pharmaceuticals Ltd (GANGAPHARM) belong to?
Ganga Pharmaceuticals Ltd (GANGAPHARM) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Ganga Pharmaceuticals Ltd (GANGAPHARM) shares?
You can directly buy Ganga Pharmaceuticals Ltd (GANGAPHARM) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Ganga Pharmaceuticals Ltd
GANGAPHARM Share Price
13.320.00% (+0.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
GANGAPHARM Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
GANGAPHARM Performance & Key Metrics
GANGAPHARM Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 0.91 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.59 | 6.40 | 0.79% |
GANGAPHARM Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
GANGAPHARM Company Profile
Ganga Pharmaceuticals is engaged in manufacturing and trading in pharmaceuticals and allied products.
SUNPHARMA
PE Ratio
36.50
36.50
1Y Return
4.00%
4.00%
Buy Reco %
87.10
87.10
CIPLA
PE Ratio
22.64
22.64
1Y Return
2.34%
2.34%
Buy Reco %
73.33
73.33
TORNTPHARM
PE Ratio
59.13
59.13
1Y Return
13.13%
13.13%
Buy Reco %
70.83
70.83
DRREDDY
PE Ratio
18.58
18.58
1Y Return
4.24%
4.24%
Buy Reco %
51.72
51.72
MANKIND
PE Ratio
52.73
52.73
1Y Return
18.31%
18.31%
Buy Reco %
81.25
81.25
GANGAPHARM Forecast
GANGAPHARM Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
GANGAPHARM
GANGAPHARM
Income
Balance Sheet
Cash Flow
Annual Normal View
GANGAPHARM Income Statement
GANGAPHARM Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3.17 | 3.20 | 3.50 | 3.25 | 2.62 | 2.75 | 2.89 | 2.98 | 3.07 | — | ||||||||||
Raw Materials | 1.06 | 1.16 | 1.21 | 1.17 | 1.42 | 1.28 | 1.34 | 1.32 | 2.75 | — | ||||||||||
| Power & Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||
| Employee Cost | 0.01 | 0.02 | 0.20 | 0.05 | 0.03 | 0.04 | 0.18 | 0.18 | ||||||||||||
| Selling & Administrative Expenses | 1.55 | 1.48 | 1.16 | 1.11 | 1.05 | 1.09 | 1.10 | 1.15 | ||||||||||||
| Operating & Other expenses | 0.08 | 0.07 | 0.37 | 0.37 | -0.15 | 0.03 | -0.04 | 0.03 | ||||||||||||
EBITDA | 0.47 | 0.47 | 0.56 | 0.55 | 0.27 | 0.31 | 0.31 | 0.30 | 0.32 | — | ||||||||||
| Depreciation/Amortization | 0.04 | 0.06 | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 | 0.05 | 0.05 | — | ||||||||||
| PBIT | 0.43 | 0.41 | 0.51 | 0.50 | 0.22 | 0.26 | 0.25 | 0.25 | 0.27 | — | ||||||||||
| Interest & Other Items | 0.32 | 0.28 | 0.25 | 0.24 | 0.19 | 0.19 | 0.19 | 0.18 | 0.18 | — | ||||||||||
| PBT | 0.11 | 0.13 | 0.26 | 0.26 | 0.03 | 0.07 | 0.06 | 0.07 | 0.09 | — | ||||||||||
| Taxes & Other Items | 0.03 | 0.03 | 0.08 | 0.06 | 0.02 | 0.01 | 0.02 | 0.02 | 0.01 | — | ||||||||||
| Net Income | 0.08 | 0.10 | 0.18 | 0.20 | 0.01 | 0.06 | 0.04 | 0.05 | 0.08 | — | ||||||||||
| EPS | 0.20 | 0.25 | 0.44 | 0.49 | 0.02 | 0.15 | 0.10 | 0.11 | 0.16 | — | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
GANGAPHARM Company Updates
GANGAPHARM Stock Peers
GANGAPHARM Past Performance & Peer Comparison
GANGAPHARM Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation-basic on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Ganga Pharmaceuticals Ltd | 80.53 | 0.91 | — |
| Sun Pharmaceutical Industries Ltd | 36.50 | 5.50 | 0.96% |
| Cipla Ltd | 22.64 | 3.82 | 1.08% |
| Torrent Pharmaceuticals Ltd | 59.13 | 14.89 | 0.18% |
GANGAPHARM Stock Price Comparison
Compare GANGAPHARM with any stock or ETFCompare GANGAPHARM with any stock or ETF
GANGAPHARM
GANGAPHARM Holdings
GANGAPHARM Shareholdings
GANGAPHARM Promoter Holdings Trend
GANGAPHARM Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
GANGAPHARM Institutional Holdings Trend
GANGAPHARM Institutional Holdings Trend
No institutional holdings trend are available
GANGAPHARM Shareholding Pattern
GANGAPHARM Shareholding Pattern
GANGAPHARM Shareholding History
GANGAPHARM Shareholding History
Foreign Institutions
smallcases containing GANGAPHARM stock
smallcases containing GANGAPHARM stock
Looks like this stock is not in any smallcase yet.
GANGAPHARM Events
GANGAPHARM Events
GANGAPHARM Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
GANGAPHARM has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
GANGAPHARM Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
GANGAPHARM has not given any dividends in last 5 years
GANGAPHARM Dividends
GANGAPHARM Dividends
Hmm, looks like data is unavailable here. Please come back after some timeGANGAPHARM Stock News & Opinions
GANGAPHARM Stock News & Opinions
Articles & Videos
Corporate
Ganga Pharmaceuticals to hold board meeting
Ganga Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 20 May 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Ganga Pharmaceuticals to announce Quarterly Result
Ganga Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 20 May 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Ganga Pharmaceuticals schedules board meeting
Ganga Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 8 November 2024Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Ganga Pharmaceuticals to hold AGM
Ganga Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on 25 September 2024.Powered by Capital Market - Live
11 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of -1.13%, vs industry avg of 10.1%
Over the last 5 years, market share stayed at 0%
Over the last 5 years, net income has grown at a yearly rate of -16.74%, vs industry avg of 20.04%